Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A “central hub” in schizophrenia pathophysiology?

Cited by (260)

Items 101–200 of 260

1. Subchronic N-acetylcysteine Treatment Decreases Brain Kynurenic Acid Levels and Improves Cognitive Performance in Mice
   Tonali Blanco Ayala, Daniela Ramírez Ortega, Paulina Ovalle Rodríguez, Benjamín Pineda, Gonzalo Pérez de la Cruz, Dinora F. González‐Esquivel, Robert M. Schwarcz, Korrapati V. Sathyasaikumar, Anabel Jiménez‐Anguiano, Verónica Pérez de la Cruz · 2021 · Antioxidants
2. Early Life and Oxidative Stress in Psychiatric Disorders: What Can we Learn From Animal Models?
   Emanuela Mhillaj, Maria Grazia Morgese, Luigia Trabace · 2015 · Current Pharmaceutical Design
3. Blood–Brain Barrier Disruption in Schizophrenia: Insights, Mechanisms, and Future Directions
   Fangsong Zhang, Jianye Zhang, Xuexue Wang, Mengyang Han, Yi Fei, Jinhong Wang · 2025 · International Journal of Molecular Sciences
4. Nonsteroidal anti-inflammatory drug, indomethacin improves spatial memory and NMDA receptor function in aged animals
   Ashok Kumar, Asha Rani, Rachel B. Scheinert, Brandi K. Ormerod, Thomas C. Foster · 2018 · Neurobiology of Aging
5. Neuronal copper homeostasis susceptibility by genetic defects in dysbindin, a schizophrenia susceptibility factor
   Avanti Gokhale, Alysia D. Vrailas‐Mortimer, Jennifer L. Larimore, Heather Skye Comstra, Stephanie A. Zlatic, Erica Werner, Daniel F. Manvich, Paul Michael Iuvone, David Weinshenker, Victor Faúndez · 2015 · Human Molecular Genetics
6. Relevance of 5-HT2A Receptor Modulation of Pyramidal Cell Excitability for Dementia-Related Psychosis: Implications for Pharmacotherapy
   Ethan S. Burstein · 2021 · CNS Drugs
7. Association Between Childhood Adversity and Functional Outcomes in People With Psychosis: A Meta-analysis
   Angeline Christy, Daniela Cavero, Sujeena Navajeeva, Rachel Murray-O’Shea, Victoria Rodríguez, Monica Aas, Giulia Trotta, Socayna Moudiab, Nathalia Garrido Torres, Blanca Zamora et al. · 2022 · Schizophrenia Bulletin
8. GABAergic system impairment in the hippocampus and superior temporal gyrus of patients with paranoid schizophrenia: A post-mortem study
   Johann Steiner, Ralf Brisch, Kolja Schiltz, Henrik Dobrowolny, Christian Mawrin, Marta Krzyżanowska, Hans‐Gert Bernstein, Zbigniew Jankowski, Katharina Braun, Andrea Schmitt et al. · 2016 · Schizophrenia Research
9. Potential Role of Antipsychotic-Galantamine-Memantine Combination in the Treatment of Positive, Cognitive, and Negative Symptoms of Schizophrenia
   Maju Mathew Koola · 2018 · Complex Psychiatry
10. Brain and body energy metabolism and potential for treatment of psychiatric disorders
    Ana C. Andreazza, L. Felipe Barros, Alexander Behnke, Dorit Ben‐Shachar, Sabina Berretta, Virginie‐Anne Chouinard, Kim Q., Sharmili Edwin Thanarajah, Hannelore Ehrenreich, Peter Falkai et al. · 2025 · Nature Mental Health
11. Galantamine-Memantine Combination as an Antioxidant Treatment for Schizophrenia
    Maju Mathew Koola, Samir Kumar Praharaj, Anilkumar Pillai · 2019 · Current Behavioral Neuroscience Reports
12. Enhanced carbonyl stress induces irreversible multimerization of CRMP2 in schizophrenia pathogenesis
    Manabu Toyoshima, Xuguang Jiang, T. Ogawa, Tetsuo Ohnishi, Shogo Yoshihara, Shabeesh Balan, Takeo Yoshikawa, Nobutaka Hirokawa · 2019 · Life Science Alliance
13. Potential drug targets and treatment of schizophrenia
    Anil Kumar, Monu Yadav, Milind Parle, Sameer Dhingra, Dinesh Kumar Dhull · 2017 · Inflammopharmacology
14. Soluble Epoxide Hydrolase Inhibitor: A Novel Potential Therapeutic or Prophylactic Drug for Psychiatric Disorders
    Qian Ren · 2019 · Frontiers in Pharmacology
15. MK-801 Exposure during Adolescence Elicits Enduring Disruption of Prefrontal E–I Balance and Its Control of Fear Extinction Behavior
    Edén Flores-Barrera, Daniel R. Thomases, Kuei Yuan Tseng · 2020 · Journal of Neuroscience
16. Investigating potential associations between neurocognition/social cognition and oxidative stress in schizophrenia
    Breno Fiúza Cruz, Salvina Maria de Campos-Carli, Amanda Margarida de Oliveira, Camila Bernardo de Brito, Zélia Menezes Garcia, Raquel Duque do Nascimento Arifa, Danielle G. Souza, Antônio Lúcio Teixeira, João Vinícius Salgado · 2021 · Psychiatry Research
17. Morphological and transcriptomic analyses of stem cell-derived cortical neurons reveal mechanisms underlying synaptic dysfunction in schizophrenia
    Annie Kathuria, Kara Lopez-Lengowski, Bradley Watmuff, Rakesh Karmacharya · 2023 · Genome Medicine
18. Novel Biomarkers of Alzheimer's Disease: Based Upon N-methyl-D-aspartate Receptor Hypoactivation and Oxidative Stress
    Ting-I Chiang, Yi‐Hsiang Yu, Chieh‐Hsin Lin, Hsien‐Yuan Lane · 2021 · Clinical Psychopharmacology and Neuroscience
19. Thiol disulfide homeostasis in psychiatric disorders: A comprehensive review
    Merve Ergin Tunçay, Murat İlhan Atagün, Özcan Erel · 2023 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
20. Low protein-induced intrauterine growth restriction as a risk factor for schizophrenia phenotype in a rat model: assessing the role of oxidative stress and neuroinflammation interaction
    Larissa Allgäuer, Jan-Harry Cabungcal, Catherine Yzydorczyk, Kim Q., Daniella Dwir · 2023 · Translational Psychiatry
21. Burden of care and quality of life in relatives of opioid dependent male subjects.
    Erdinc Cicek, Başak Demirel, Halil Ibrahim Ozturk, Fatih Kayhan, Ismet Esra Cicek, Ibrahim Eren · 2015 · PubMed
22. Schizophrenia Increases Variability of the Central Antioxidant System: A Meta-Analysis of Variance From MRS Studies of Glutathione
    Lena K. Palaniyappan, Priyadharshini Sabesan, Xuan Li, Qiang Luo · 2021 · Frontiers in Psychiatry
23. Characterization of <scp>l</scp>-Theanine Excitatory Actions on Hippocampal Neurons: Toward the Generation of Novel <i>N</i>-Methyl-<scp>d</scp>-aspartate Receptor Modulators Based on Its Backbone
    Sebih, Fatiha, Rousset, Matthieu, Bellahouel, Salima, Rolland, Marc, de Jesus Ferreira, Marie Celeste, Guiramand, Janique, Cohen-Solal, Catherine, Barbanel, Gérard, Cens, Thierry, Abouazza, Mohammed et al. · 2017 · ACS Chemical Neuroscience
24. Novel Pullulan/Gellan Gum Bilayer Film as a Vehicle for Silibinin-Loaded Nanocapsules in the Topical Treatment of Atopic Dermatitis
    Mailine Gehrcke, Carolina C. Martins, Taíne de Bastos Brum, Lucas Saldanha da Rosa, Cristiane Luchese, Ethel Antunes Wilhelm, Fábio Zovico Maxnuck Soares, Letícia Cruz · 2022 · Pharmaceutics
25. Blockade of platelet-activating factor receptor attenuates abnormal behaviors induced by phencyclidine in mice through down-regulation of NF-κB.
    The-Vinh Tran, S. J. Park, E. Shin, Hai-Quyen Tran, J. Jeong, C. Jang, Yu-Jeung Lee, S. Nah, T. Nabeshima, Hyoung-Chun Kim · 2018 · Brain Research Bulletin
26. Role of Neural Stem Cells and Vitamin D Receptor (VDR)–Mediated Cellular Signaling in the Mitigation of Neurological Diseases
    Chinnappa A. Uthaiah, Narasimha Murthy Beeraka, R. Rajalakshmi, Ramya C. M., SubbaRao V. Madhunapantula · 2022 · Molecular Neurobiology
27. Characterization of a Novel Mutation in SLC1A1 Associated with Schizophrenia
    Parisa Afshari, Marina Myles‐Worsley, Ori S. Cohen, Josepha Tiobech, Stephen V. Faraone, William Byerley, Frank A. Middleton · 2015 · Complex Psychiatry
28. Reduced Slc1a1 expression is associated with neuroinflammation and impaired sensorimotor gating and cognitive performance in mice: Implications for schizophrenia
    Parisa Afshari, Wei‐Dong Yao, Frank A. Middleton · 2017 · PLoS ONE
29. Networks of blood proteins in the neuroimmunology of schizophrenia
    Clark D. Jeffries, Diana O. Perkins, Margot Fournier, Kim Q., Michel Cuénod, Inès Khadimallah, Enrico Domenici, Jean Addington, Carrie E. Bearden, Kristin S. Cadenhead et al. · 2018 · Translational Psychiatry
30. Gene set enrichment analysis of pathophysiological pathways highlights oxidative stress in psychosis
    Giorgio Pistis, Javier Vázquez-Bourgón, Margot Fournier, Raoul Jenni, Martine Cleusix, Sergi Papiol, Sophie E. Smart, Antonio F. Pardiñas, James Walters, James Hunter MacCabe et al. · 2022 · Molecular Psychiatry
31. Targeting d-Amino Acid Oxidase (DAAO) for the Treatment of Schizophrenia: Rationale and Current Status of Research
    Chien-Yi Kuo, Chieh‐Hsin Lin, Hsien‐Yuan Lane · 2022 · CNS Drugs
32. Physical Exercise Alleviates Health Defects, Symptoms, and Biomarkers in Schizophrenia Spectrum Disorder
    Trevor Archer, Richard M. Kostrzewa · 2015 · Neurotoxicity Research
33. Cannabinoids and glial cells: possible mechanism to understand schizophrenia
    Valéria de Almeida, Daniel Martins‐de‐Souza · 2018 · European Archives of Psychiatry and Clinical Neuroscience
34. Ionotropic glutamate receptor expression in human white matter
    Pia Crone Christensen, Zahra Samadi‐Bahrami, Vlady Pavlov, Peter K. Stys, G. R. Wayne Moore · 2016 · Neuroscience Letters
35. Differences in omega‐3 and omega‐6 polyunsaturated fatty acid consumption in people at ultra‐high risk of psychosis, first‐episode schizophrenia, and in healthy controls
    Tomasz Pawełczyk, Elżbieta Trafalska, Agnieszka Maria Pawełczyk, Magdalena Kotlicka‐Antczak · 2015 · Early Intervention in Psychiatry
36. Implication of the glutamate–cystine antiporter xCT in schizophrenia cases linked to impaired GSH synthesis
    Margot Fournier, Aline Monin, Carlotta Ferrari, Philipp Baumann, Philippe Conus, K. Do · 2017 · Schizophrenia
37. Postnatal Antioxidant and Anti-inflammatory Treatments Prevent Early Ketamine-Induced Cortical Dysfunctions in Adult Mice
    María Bové, Paolo Tucci, Stefania Dimonte, Luigia Trabace, Stefania Schiavone, Maria Grazia Morgese · 2020 · Frontiers in Neuroscience
38. Long‐Term Effects of Maternal Deprivation on Redox Regulation in Rat Brain: Involvement of NADPH Oxidase
    Branka Marković, Nevena V. Radonjić, G. Jevtić, T. Stojković, Milica Velimirović, Milan Aksić, Joko Poleksić, Tatjana Nikolić, Dubravka Aleksić, Vidosava Radonjić et al. · 2017 · Oxidative Medicine and Cellular Longevity
39. Human Aquaporin 4 Gene Polymorphisms and Haplotypes Are Associated With Serum S100B Level and Negative Symptoms of Schizophrenia in a Southern Chinese Han Population
    Yung-Fu Wu, Huey‐Kang Sytwu, For‐Wey Lung · 2018 · Frontiers in Psychiatry
40. Repetitive Behaviors Treated With N-Acetylcysteine: Case Series.
    Faruk Kılıç, S. Keleş · 2019 · Clinical neuropharmacology
41. Recent Reports on Redox Stress-Induced Mitochondrial DNA Variations, Neuroglial Interactions, and NMDA Receptor System in Pathophysiology of Schizophrenia
    Narasimha Murthy Beeraka, Marco Ávila-Rodriguez, Gjumrakch M. Aliev · 2022 · Molecular Neurobiology
42. Analysis of differential gene expression mediated by clozapine in human postmortem brains
    Brian J. Lee, Luigi Marchionni, Carrie E. Andrews, Alexis L. Norris, Leslie G. Nucifora, YeeWen Candace Wu, Robert A. Wright, Jonathan Pevsner, Christopher A. Ross, Russell L. Margolis et al. · 2016 · Schizophrenia Research
43. A Novel Bio-Psychosocial-Behavioral Treatment Model in Schizophrenia
    Yong‐Ku Kim, Joonho Choi, Seon‐Cheol Park · 2017 · International Journal of Molecular Sciences
44. Glutathione Deficiency during Early Postnatal Development Causes Schizophrenia-Like Symptoms and a Reduction in BDNF Levels in the Cortex and Hippocampus of Adult Sprague–Dawley Rats
    M. A. Lech, M. Leśkiewicz, K. Kamińska, Z. Rogóż, E. Lorenc-Koci · 2021 · International Journal of Molecular Sciences
45. Glutathione as a Molecular Marker of Functional Impairment in Patients with At-Risk Mental State: 7-Tesla 1H-MRS Study
    Peter Jeon, R. Limongi, Sabrina D. Ford, C. Branco, Michael Mackinley, M. Gupta, Laura Powe, J. Théberge, L. Palaniyappan · 2020 · medRxiv
46. Schizophrenia and Glutathione: A Challenging Story
    Barbara Carletti, Nerisa Banaj, Fabrizio Piras, Paola Bossù · 2023 · Journal of Personalized Medicine
47. Social isolation stress and chronic glutathione deficiency have a common effect on the glutamine‐to‐glutamate ratio and myo‐inositol concentration in the mouse frontal cortex
    Alberto Corcoba, Rolf Gruetter A, Kim Q., João M. N. Duarte · 2017 · Journal of Neurochemistry
48. The Role of Neuroglia in the Development and Progression of Schizophrenia
    Neha S. Rawani, Allen W. Chan, Kathryn G. Todd, Glen B. Baker, Serdar Murat Dursun · 2024 · Biomolecules
49. The Redox Biology of Excitotoxic Processes: The NMDA Receptor, TOPA Quinone, and the Oxidative Liberation of Intracellular Zinc
    Elias Aizenman, Ralph H. Loring, Ian J. Reynolds, Paul A. Rosenberg · 2020 · Frontiers in Neuroscience
50. Integrative Pharmacology in the Treatment of Substance Use Disorders
    Jack Donlon, Pooja Kumari, Sajoy Purathumuriyil Varghese, Michael Y. Bai, Ori David Florentin, Emma D. Frost, John Banks, Niyathi Vadlapatla, Olivia Kam, Mujeeb Uddin Shad et al. · 2023 · Journal of Dual Diagnosis
51. Integrative Analysis of Disease Signatures Shows Inflammation Disrupts Juvenile Experience-Dependent Cortical Plasticity
    Milo R. Smith, Poromendro Burman, Masato Sadahiro, Brian A. Kidd, Joel T. Dudley, Hirofumi Morishita · 2016 · eNeuro
52. Aerobic Exercise Improves the Overall Outcome of Type 2 Diabetes Mellitus Among People With Mental Disorders
    Jiaxuan He, Fan Liu, Peiye Xu, Ting Xu, Haiyang Yu, Baihui Wu, Hanbing Wang, Jia Chen, Kun Zhang, Junbei Zhang et al. · 2024 · Depression and Anxiety
53. Efficacy and acceptability of adjunctive n‐acetylcysteine for psychotic disorders: Systematic review and meta‐analysis
    Qun Zhang, Ziping Liu, Ting Wang, Min Yu, Xiaoqian Li · 2023 · Human Psychopharmacology Clinical and Experimental
54. The Pathophysiological Underpinnings of Gamma-Band Alterations in Psychiatric Disorders
    Annalisa Palmisano, Siddhartha Pandit, Carmelo Luca Smeralda, Ilya Demchenko, Símone Rossi, Lorella Battelli, Davide Rivolta, Venkat Bhat, Emiliano Santarnecchi · 2024 · Life
55. Connecting Neurobiological Features with Interregional Dysconnectivity in Social-Cognitive Impairments of Schizophrenia
    Florian W. Adraoui, Linda Douw, Gerard J.M. Martens, Dorien A. Maas · 2023 · International Journal of Molecular Sciences
56. Exploration of the relationship between hippocampus and immune system in schizophrenia based on immune infiltration analysis
    Yanhong Du, Yao Gao, Guangxian Wu, Zexuan Li, Xinzhe Du, Junxia Li, Xinrong Li, Zhifen Liu, Yong Xu, Sha Liu · 2022 · Frontiers in Immunology
57. Biphasic Modulation of NMDA Receptor Function by Metabotropic Glutamate Receptors
    Nathanael O’Neill, Catherine McLaughlin, Noboru H. Komiyama, Sergiy Sylantyev · 2018 · Journal of Neuroscience
58. Deletion of the Mitochondrial Matrix Protein CyclophilinD Prevents Parvalbumin Interneuron Dysfunctionand Cognitive Deficits in a Mouse Model of NMDA Hypofunction
    Aarron J. Phensy, Kathy L. Lindquist, Karen A. Lindquist, Dania Bairuty, Esha Gauba, Lan Guo, Jing Tian, Heng Du, Sven Kroener · 2020 · Journal of Neuroscience
59. Multitarget Derivatives of D2AAK1 as Potential Antipsychotics: The Effect of Substitution in the Indole Moiety
    Magda Kondej, Tomasz M. Wróbel, Katarzyna M. Targowska‐Duda, Antón Leandro Martínez, Oliwia Koszła, Piotr Stępnicki, Agata Zięba, Alba Paz, Olga Wronikowska‐Denysiuk, Marı́a Isabel Loza et al. · 2022 · ChemMedChem
60. New Insights Regarding Diagnosis and Medication for Schizophrenia Based on Neuronal Synapse–Microglia Interaction
    Naotaka Izuo, Atsumi Nitta · 2021 · Journal of Personalized Medicine
61. The role of neuroinflammation in PV interneuron impairments in brain networks; implications for cognitive disorders
    Pantea Allami, Niloufar Yazdanpanah, Nima Rezaei · 2025 · Reviews in the Neurosciences
62. Oxidative Stress in the Early Stage of Psychosis
    Antonio Ventriglio, Antonello Bellomo, Donato Favale, Iris Bonfitto, Giovanna Vitrani, Di Sabatino Dario, Edwige Cuozzo, Di Gioia Ilaria, Mauro Pettorruso, Giampaolo Perna et al. · 2021 · Current Topics in Medicinal Chemistry
63. Enhanced storage capacity with errors in scale-free Hopfield neural networks: An analytical study
    Do-Hyun Kim, Jinha Park, B. Kahng · 2017 · PLoS ONE
64. A Perspective on a Possible Relation Between the Psychopathology of the Schizophrenia/Schizoaffective Spectrum and Unconjugated Bilirubin: A Longitudinal Protocol Study
    João Gama Marques, Filipe Arantes-Gonçalves · 2018 · Frontiers in Psychiatry
65. Behavioral and molecular effects of the antipsychotic drug blonanserin in the chronic mild stress model
    Maria Serena Paladini, Vittoria Spero, Veronica Begni, Francesca Marchisella, Alice Guidi, Piotr Gruca, Magdalena Łasoń, Ewa Litwa, Mariusz Papp, Marco Andrea Riva et al. · 2020 · Pharmacological Research
66. Links of platelet glutamate and glutathione metabolism with attenuated positive and negative symptoms in depressed patients at clinical high risk for psychosis
    И. С. Бокша, Maria A. Omelchenko, Olga Konstantinovna Savushkina, T. A. Prokhorova, Е. Б. Терешкина, E. A. Vorobyeva, Gulnur Sh. Burbaeva · 2022 · European Archives of Psychiatry and Clinical Neuroscience
67. Immune Cell Ratios Are Higher in Bipolar Affective than Unipolar Depressive Disorder and Modulated by Mood Episode: A Retrospective, Cross-Sectional Study
    Koureta, Anastasia, Asimakopoulos, Lampros O., Bozikas, Vasilios P., Agorastos, Agorastos · 2023 · Brain Sciences
68. Bioenergetic impairment in schizophrenia: role of mitochondrial signaling in synaptic dysfunction - a systematic review
    Valerio Ricci, Giovanni Martinotti, Alessio Mosca, Giuseppe Maina · 2026 · Frontiers in Cell and Developmental Biology
69. IUPHAR review – Novel therapeutic targets for schizophrenia treatment: A translational perspective
    Veronica Begni, Alessia Marchesin, Marco Andrea Riva · 2025 · Pharmacological Research
70. N-acetylcysteine improves EEG measures of auditory deviance detection and neural synchronization in schizophrenia: A randomized, controlled pilot study
    Yvonne S. Yang, Michael C. Davis, Jonathan K. Wynn, Gerhard Hellemann, Michael Foster Green, Stephen R. Marder · 2019 · Schizophrenia Research
71. White Matter Alterations Between Brain Network Hubs Underlie Processing Speed Impairment in Patients With Schizophrenia
    Paul Klauser, Vanessa Cropley, Philipp S Baumann, Jinglei Lv, Pascal Steullet, Daniella Dwir, Yasser Alemán‐Gómez, Meritxell Bach Cuadra, Michel Cuénod, Kim Q. et al. · 2021 · Schizophrenia Bulletin Open
72. Role of Redox Dysregulation in White Matter Anomalies Associated with Schizophrenia
    Aline Monin, Margot Fournier, Philipp Baumann, Michel Cuénod, Kim Q. · 2015 · Handbook of behavioral neuroscience
73. Activity of enzymes of glutamate, energy and glutathione metabolism in the first juvenile depression with attenuated symptoms of schizophrenia
    Olga Konstantinovna Savushkina, И. С. Бокша, Maria A. Omelchenko, Е. Б. Терешкина, T. A. Prokhorova, E. A. Vorobyeva, Gulnur Sh. Burbaeva · 2022 · S S Korsakov Journal of Neurology and Psychiatry
74. Neurocognition and NMDAR co-agonists pathways in individuals with treatment resistant first-episode psychosis: a 3-year follow-up longitudinal study
    Sara Camporesi, Lijing Xin, Philippe Golay, Chin B. Eap, Martine Cleusix, Michel Cuénod, Margot Fournier, Kenji Hashimoto, Raoul Jenni, Julie Ramain et al. · 2024 · Molecular Psychiatry
75. NMDAR dysfunction and the regulation of dopaminergic transmission in schizophrenia
    Gerard Eric Dwyer, Erik Johnsen, Kenneth Hugdahl · 2024 · Schizophrenia Research
76. No alteration of leukocyte telomere length in first episode psychosis
    Franck Schürhoff, Cécile Corfdir, Baptiste Pignon, Mohamed Lajnef, Jean‐Romain Richard, Élisabeth Marcos, Antoine Pélissolo, Marion Leboyer, Serge Adnot, Stéphane Jamain et al. · 2021 · Psychiatry Research
77. Bridging the gaps towards precision psychiatry: Mechanistic biomarkers for early detection and intervention
    Kim Q. · 2023 · Psychiatry Research
78. Topology predicts long-term functional outcome in early psychosis
    Margot Fournier, Martina Scolamiero, Mehdi Gholam‐Rezaee, Martine Cleusix, Raoul Jenni, Carina Ferrari, Philippe Golay, Philipp Baumann, Michel Cuénod, Philippe Conus et al. · 2020 · Molecular Psychiatry
79. Is it possible to prevent excessive synaptic pruning in schizophrenia? Possibilities and limitations
    Agnieszka Pawlak, Jakub Stefanowicz, Zofia Kotkowska, Agata Gabryelska, Marcin Sochal, Filip Napieraj, Magdalena Kotlicka‐Antczak, Dominik Strzelecki · 2025 · Frontiers in Synaptic Neuroscience
80. Brain Neuroplasticity Mechanisms in Psychiatric Illnesses and in the Development of Novel Treatments
    Patricio O’Donnell, Amit Etkin, Husseini K. Manji · 2026 · American Journal of Psychiatry
81. Upregulation of vitamin D-related genes in schizophrenic patients
    Fateme Asadzadeh Manjili, Seyed Mehdi Kalantar, Shahram Arsang‐Jang, Soudeh Ghafouri‐Fard, Mohammad Naser Taheri, Arezou Sayad · 2018 · Neuropsychiatric Disease and Treatment
82. Dopaminergic responses in the core part of the nucleus accumbens to subcutaneous MK801 administration are increased following postnatal transient blockade of the prefrontal cortex
    Emmanuelle Tagliabue, Tiphaine Pouvreau, Séverine Eybrard, Francisca Meyer, Alain Louilot · 2017 · Behavioural Brain Research
83. The Inflammatory Nexus: Unraveling Shared Pathways and Promising Treatments in Alzheimer’s Disease and Schizophrenia
    Aurelio Pio Russo, Ylenia Pastorello, Lóránd Dénes, Klara Brînzaniuc, Jerzy Krupiński, MARK A. SLEVIN · 2025 · International Journal of Molecular Sciences
84. Unlocking new avenues for neuropsychiatric disease therapy: the emerging potential of Peroxisome proliferator-activated receptors as promising therapeutic targets
    Asmita Deka Dey, Ashi Mannan, Sonia Dhiman, Thakur Gurjeet Singh · 2024 · Psychopharmacology
85. Memantine/Rosuvastatin Therapy Abrogates Cognitive and Hippocampal Injury in an Experimental Model of Alzheimer's Disease in Rats: Role of TGF-β1/Smad Signaling Pathway and Amyloid-β Clearance
    Esraa F. Zidan, Nesrine S. El-Mezayen, Safaa H. El‐Rewini, Elham A. Afify, Mennatallah A. Ali · 2024 · Journal of Neuroimmune Pharmacology
86. Dominant-Negative DISC1 Alters the Dopaminergic Modulation of Inhibitory Interneurons in the Mouse Prefrontal Cortex
    Ross A. Cardarelli, Rolicia F. Martin, Hanna Jaaro-Peled, Akira Sawa, Elizabeth M. Powell, Patricio O’Donnell · 2018 · Complex Psychiatry
87. Examining the immune signatures of SARS-CoV-2 infection in pregnancy and the impact on neurodevelopment: Protocol of the SIGNATURE longitudinal study
    Nathalia Garrido Torres, Lucas Cerrillos, Susana García-Cerro, Alberto Pérez‐Gómez, Manuel Canal‐Rivero, Beatriz de Felipe, Luis Alameda, Renata Marqués Rodríguez, Sergio Anillo, Julia Praena et al. · 2022 · Frontiers in Pediatrics
88. Dopamine D4 Receptor Agonist Drastically Increases Delta Activity in the Thalamic Nucleus Reuniens: Potential Role in Communication between Prefrontal Cortex and Hippocampus
    J. Kuang, Vasilios Kafetzopoulos, Richard C. Deth, Bernát Kocsis · 2023 · International Journal of Molecular Sciences
89. Inhibition of reactive oxygen species production accompanying alternatively activated microglia by risperidone in a mouse ketamine model of schizophrenia
    Risako Fujikawa, Jun Yamada, Shoichiro Maeda, Kyoko Iinuma, Genki Moriyama, Shozo Jinno · 2024 · Journal of Neurochemistry
90. Brain glutathione levels and age at onset of illness in chronic schizophrenia
    Yvonne S. Yang, Richard J. Maddock, Junghee Lee, Huailin Zhang, Gerhard Hellemann, Katherine L. Narr, Stephen R. Marder, Michael Foster Green · 2019 · Acta Neuropsychiatrica
91. Impact of repeated co-treatment with escitalopram and aripiprazole on the schizophrenia-like behaviors and BDNF mRNA expression in the adult Sprague–Dawley rats exposed to glutathione deficit during early postnatal development of the brain
    Marta Anna Lech, Kinga Kamińska, Monika Leśkiewicz, Elżbieta Lorenc‐Koci, Zofia Rogóż · 2021 · Pharmacological Reports
92. Psychologically Traumatic Oxidative Stress; A Comprehensive Review of Redox Mechanisms and Related Inflammatory Implications
    Evangelos Karanikas · 2025 · Psychopharmacology Bulletin
93. Metabolomic profiling reveals a differential role for hippocampal glutathione reductase in infantile memory formation
    Benjamin Bessières, Emmanuel Cruz, Cristina M. Alberini · 2021 · eLife
94. Clozapine mitigates MK-801-induced mismatch negativity impairment in a rat electroencephalography study: relevance for schizophrenia drug development
    Florian W. Adraoui, Maëlle Violas, Geoffrey Viardot, Kenza Hettak, Samuel Tugler, Eric Delpy, Anne Maurin, Philippe L’Hostis, Christophe Drieu La Rochelle, Kévin Carvalho · 2025 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
95. Effect of N-Acetylcysteine on Sleep: Impacts of Sex and Time of Day
    Priyanka N. Bushana, Michelle A. Schmidt, Kevin M. Chang, Trisha Vuong, Barbara A. Sorg, Jonathan P. Wisor · 2023 · Antioxidants
96. N-acetylcysteine: An Innovative Approach to Obsessive-Compulsive Disorder Treatment: A Narrative Review
    Sadia Binte Anwar Sonia, Muhammad Nurul Alam Siddiki, Sarmin Sultana, Iftekhar Hossain Chowdhury, Susmita Sinha, Rahnuma Ahmad, Miral Mehta, Mainul Haque · 2025 · Advances in Human Biology
97. Microglia Activation in Subjects at Risk for Psychosis: Fact or Fiction?
    Patricio O’Donnell · 2017 · Neuropsychopharmacology
98. Urinary biopyrrins and free immunoglobin light chains are biomarker candidates for screening at‐risk mental state in adolescents
    Rei Wake, Tomoko Araki, Michiyo Fukushima, Hiroyuki Matsuda, Takuji Inagaki, Maiko Hayashida, Sadayuki Hashioka, Jun Horiguchi, Masatoshi Inagaki, Tsuyoshi Miyaoka et al. · 2021 · Early Intervention in Psychiatry
99. Interaction between peripheral and central immune markers in clinical high risk for psychosis
    Kankana Nisha Aji, Sina Hafizi, Tânia Maria Sarmento Silva, Michael Kiang A, Pablo Rusjan, Cynthia Shannon Weickert, Romina Mizrahi · 2023 · Brain Behavior & Immunity - Health
100. Sleep spindles across youth affected by schizophrenia or anti-N-methyl-D-aspartate-receptor encephalitis
     Maria E. Dimitriades, Andjela Markovic, Silvano R. Gefferie, Ashura Williams Buckley, David I. Driver, Judith L. Rapoport, Margherita Nosadini, Kevin M. Rostasy, Stefano Sartori, Agnese Suppiej et al. · 2023 · Frontiers in Psychiatry